Outcomes based on the MRD status in patients with mixed T-cell chimerism and full donor T-cell chimerism. Mixed T-cell chimerism ([A] OS [B] RFS) or full donor T-cell chimerism ([C] OS, [D] RFS). Mixed chimerism is defined as <95% donor:host CD3⁺ T-cell ratio at month >3 or 6; Full chimerism is defined as >95% donor:host CD3⁺ T-cell ratio at month >3 and 6. MRD status defined from results up to month >6 for patients with full donor chimerism or up to the time point of mixed chimerism result.